GLP-1 and PCOS: Pre-Start Provider Checklist for Weight-Loss Planning

Where GLP-1 options may fit in PCOS planning

PCOS often includes insulin resistance and weight-related risk, but symptom profiles vary across patients. Because of that, no single medication strategy is universal.

Before adding any anti-obesity medication, align on the core target: weight trend, metabolic markers, menstrual regularity goals, or a combined endpoint.

The strongest plans explicitly state what will be measured and when, so progress is not judged by short-term noise.

Sources: [1] [2] [5] [6]

Pre-start provider checklist (table-style)

Treat this as a live checklist, not a one-time form. The goal is to improve continuity and reduce reactive plan changes.

• Clinical baseline: current weight trend, blood pressure, glucose markers, and symptom priorities.
• PCOS context: cycle pattern, androgen-related symptoms, and current medications that may influence weight/metabolic response.
• Reproductive planning: clarify pregnancy intentions and timing, and review medication implications with your clinician.
• Medication pathway: compare route, titration schedule, expected tolerability, and follow-up intervals.
• Decision rules: define in advance what counts as meaningful progress at 8-12 weeks and what triggers re-evaluation.

Sources: [1] [2] [3] [4] [5] [6]

Questions that prevent avoidable restarts

• Which outcomes matter most for this phase of my PCOS care?
• How should we titrate if side effects appear during escalation?
• What nutrition and activity targets should accompany medication?
• When should we reassess for a different option if adherence or tolerability is low?

Sources: [2] [3] [4] [6]

Bottom line

For PCOS patients, GLP-1 consideration is most useful when built into a structured, milestone-based care discussion.

A clear pre-start checklist can improve fit, reduce confusion, and support safer long-term planning.

Sources: [1] [2] [3]